We are thrilled to announce the launch of our brand new website: www.luminarygroup.co.uk Luminary Group, is an international executive search and business consultancy specializing in the Life Sciences and Pharmaceutical sectors. Contact us today! #NewWebsite #LuminaryGroup #DigitalLaunch #ExploreNow
About us
Luminary Group is a international business consultancy focused on the life sciences and pharmaceutical sectors. Headquartered at St Magnus House, 3 Lower Thames Street, Central London, EC3R 6HD, we deliver comprehensive services in three key areas. Luminary Executive: Specializing in C-suite to Director-level appointments, we identify top talent for positions including Chairman, Board members, CEO, CCO, COO, AVP to Director level. Luminary Staffing: We provide both temporary and permanent staffing solutions tailored to meet the commercial, project management, medical, biometrics, software and operational needs of our clients. Luminary Consulting: Offering high-quality services in medical writing, regulatory affairs, quality assurance, pharmacovigilance, and data science for the medical and pharmaceutical industries. We also provide strategic partnerships to accelerate growth through Recruitment Process Outsourcing (RPO) and Functional Service Provider (FSP) services. Lastly, our advisory services assist in data partnerships, leveraging our extensive network of leading RWE, RWD, and AI enterprises across the US and Europe, and provide guidance for business collaborations with biotechnology firms and navigating mergers and acquisitions. Our expertise includes Real World Evidence (RWE), eClinical solutions, Artificial Intelligence (AI), Biotechnology, Consulting, and Medical Devices. Operating globally with a presence in the USA, Europe, APAC, and the Middle East, we take pride in our exclusive talent pool, ranging from C-Suite to Managerial levels, and our partnerships with returning clients and candidates. Our collaborations extend across a diverse range of companies, from corporate giants to innovative start-ups. For more information, please visit our website: www.luminarygroup.co.uk.
- Website
-
www.luminarygroup.co.uk
External link for Luminary Group
- Industry
- Business Consulting and Services
- Company size
- 11-50 employees
- Headquarters
- City of London
- Type
- Privately Held
- Founded
- 2023
- Specialties
- Executive Search, Headhunting, Consulting, Life Sciences, Pharmacovigilence, Regulatory Affairs, CMC, Biotechnology, Diagnostics, CRO, Clinical Trials, Cell & Gene Therapy, Machine Learning, Real World Evidence, Real World Data, eClinical, eCOA, RPO, FSP, Corporate Development, Partnerships, Data Partnerships, RWE, RWD, and Artificial Intelligence
Locations
-
Primary
City of London , GB
-
4th St N, STE 300
7901
St. Petersburg, FL , 33702, US
Employees at Luminary Group
Updates
-
We are excited to announce the expansion of our team with the addition of our very first US employee after 1 year and 8 months in business! Please join us in welcoming Evelyn Dougherty as our Senior Partner - USA, who will be spearheading our growth from our new office in Miami, Florida. 🇺🇸 Evelyn brings a wealth of experience as a specialist headhunter in the Life Sciences industry, focusing on connecting top talent with leading companies in niche areas such as Real World Evidence (RWE), Health Economics and Outcomes Research (HEOR), and Real World Data (RWD). With over 4 years of experience, she has developed deep expertise in these specialized sectors, covering various commercial roles like Business Developers, Product Managers, Marketing, and Customer Success professionals, particularly within HEOR and RWE companies and vendors. Evelyn has a strong track record in Executive Search and the commercial domain, successfully placing high-level roles such as Business Development Directors, Account Directors, Strategic Alliances, and Corporate Development roles. Her passion lies in connecting professionals who excel in selling RWE and HEOR solutions and services with opportunities that perfectly align with their skills and aspirations. Welcome to the team, Evelyn! 🚀
-
-
Luminary Group reposted this
𝗖𝗲𝗹𝗹 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝘀𝘁𝗮𝗿𝘁𝘂𝗽 𝗔𝗿𝘀𝗲𝗻𝗮𝗹𝗕𝗶𝗼 𝗿𝗮𝗶𝘀𝗲𝘀 $𝟯𝟮𝟱𝗠 𝗮𝘀 𝗶𝘁 𝗿𝘂𝗻𝘀 𝗲𝗮𝗿𝗹𝘆 𝘀𝗼𝗹𝗶𝗱 𝘁𝘂𝗺𝗼𝗿 𝘁𝗿𝗶𝗮𝗹𝘀 CAR T cell therapy startup Arsenal Biosciences, Inc. has reeled in a $325 million Series C as it works through two early-stage trials … https://lnkd.in/ed6whQGB
-
𝗖𝗲𝗹𝗹 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝘀𝘁𝗮𝗿𝘁𝘂𝗽 𝗔𝗿𝘀𝗲𝗻𝗮𝗹𝗕𝗶𝗼 𝗿𝗮𝗶𝘀𝗲𝘀 $𝟯𝟮𝟱𝗠 𝗮𝘀 𝗶𝘁 𝗿𝘂𝗻𝘀 𝗲𝗮𝗿𝗹𝘆 𝘀𝗼𝗹𝗶𝗱 𝘁𝘂𝗺𝗼𝗿 𝘁𝗿𝗶𝗮𝗹𝘀 CAR T cell therapy startup Arsenal Biosciences, Inc. has reeled in a $325 million Series C as it works through two early-stage trials … https://lnkd.in/ed6whQGB
Cell therapy startup ArsenalBio raises $325M as it runs early solid tumor trials
endpts.com
-
𝗣𝗮𝘁𝗶𝗲𝗻𝘁𝗣𝗮𝗿𝘁𝗻𝗲𝗿 𝗿𝗮𝗶𝘀𝗲𝘀 $𝟳𝗠 𝘁𝗼 𝗵𝗲𝗹𝗽 𝗽𝗵𝗮𝗿𝗺𝗮 𝗰𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗺𝗮𝘁𝗰𝗵 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝘄𝗶𝘁𝗵 𝗺𝗲𝗻𝘁𝗼𝗿𝘀 PatientPartner a startup … Patrick Frank, George Kramb https://lnkd.in/dEVBm68A
Exclusive: PatientPartner raises $7M to help pharma companies match patients with mentors
endpts.com
-
𝗩𝗮𝘅𝗰𝘆𝘁𝗲 𝘀𝘂𝗿𝗴𝗲𝘀 𝗼𝗻 𝗣𝗵𝗮𝘀𝗲 𝟭/𝟮 𝗱𝗮𝘁𝗮 𝗳𝗼𝗿 𝟯𝟭-𝘃𝗮𝗹𝗲𝗻𝘁 𝗽𝗻𝗲𝘂𝗺𝗼𝗰𝗼𝗰𝗰𝗮𝗹 𝘃𝗮𝗰𝗰𝗶𝗻𝗲 Vaxcyte shares $PCVX jumped more than 35% Tuesday morning on the heels of Phase 1/2 data for its 31-valent pneumococcal conjugate vaccine, VAX-31, being tested …Grant Pickering https://lnkd.in/d87ACJPB
Vaxcyte surges on Phase 1/2 data for 31-valent pneumococcal vaccine
endpts.com
-
𝗔𝗿𝗿𝗼𝘄𝗵𝗲𝗮𝗱 𝘀𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁𝘀 𝗸𝗲𝘆 𝗽𝗮𝗻𝗰𝗿𝗲𝗮𝘁𝗶𝘁𝗶𝘀 𝗳𝗶𝗴𝘂𝗿𝗲𝘀 𝗳𝗿𝗼𝗺 𝗣𝗵𝗮𝘀𝗲 𝟯 𝗹𝗶𝗽𝗶𝗱 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝘀𝘁𝘂𝗱𝘆 𝘁𝗼 𝗱𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝘁𝗶𝗮𝘁𝗲 𝗶𝘁𝘀𝗲𝗹𝗳 𝗳𝗿𝗼𝗺 𝗜𝗼𝗻𝗶𝘀 Arrowhead Pharmaceuticals has unveiled highly anticipated pancreatitis results from a late-phase trial of plozasiran for a rare lipid disorder, several months after reporting topline data … https://lnkd.in/dUKSFqrn
Arrowhead spotlights key pancreatitis figures from Phase 3 lipid disease study to differentiate itself from Ionis
endpts.com
-
𝗙𝗗𝗔 𝗮𝘂𝘁𝗵𝗼𝗿𝗶𝘇𝗲𝘀 𝗡𝗼𝘃𝗮𝘃𝗮𝘅'𝘀 𝘂𝗽𝗱𝗮𝘁𝗲𝗱 𝗖𝗼𝘃𝗶𝗱 𝗯𝗼𝗼𝘀𝘁𝗲𝗿 The FDA has authorized emergency use of Novavax updated Covid booster, just over a week after clearing updated versions of mRNA boosters … https://lnkd.in/dvhE_96V
FDA authorizes Novavax's updated Covid booster
endpts.com
-
We’re excited to participate in ELRIG UK Drug Discovery 2024! Join Serena, Jess and Faisal at ExCeL London this October for one of the largest European conferences in the drug discovery community. #Conference #ELRIG #Drugdiscovery #ELRIG
-
-
Happy Labor Day to all our employees, clients, candidates, and contractors in the USA! 🇺🇸 Today, we celebrate your hard work, dedication, and contributions. Enjoy a well-deserved break! #LaborDay #ThankYou #Gratitude #Celebration
-